Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Chronic Kidney Disease
60%
Alcoholic Cirrhosis
50%
NELL-1
50%
Calciphylaxis
50%
SIADH
50%
Membranous Nephropathy
50%
Anti-endothelial Cell Antibodies
50%
CYP24A1 Gene
50%
Acute Kidney Injury
50%
Diabetes Insipidus
50%
Scleroderma
50%
Pulmonary Fibrosis
50%
Hypernatremia
50%
Hyponatremia
50%
Hemodialysis Graft
50%
Western Blot Analysis
50%
Oxalate Nephropathy
50%
MIBG Therapy
50%
Nephrolithiasis
50%
Fluid Resuscitation
50%
Blind Loop
50%
Stent Placement
50%
α-lactalbumin (α-La)
50%
Scoping Review
50%
Thrombus
50%
Ketoconazole
50%
Sepsis Management
50%
Fusobacterium Infections
50%
Digital Equity
50%
COVID-19
50%
End-stage Renal Disease
50%
Compound Heterozygous mutation
50%
Neural Epidermal Growth Factor-like 1
43%
Secondary Oxalate Nephropathy
30%
Hyperoxaluria
30%
Emergency Situation
26%
Differential Diagnosis
26%
Serum Sodium
26%
Emergency Treatment
26%
Most Common Cause
26%
Adjusted Odds Ratio
25%
Idiopathic Infantile Hypercalcemia
25%
Rodent Lungs
25%
Renal Function
25%
Gain-of-function mutation
25%
Vitamin D Status
25%
Calciuria
25%
25-hydroxyvitamin D (25OHD)
25%
Treatment Options
25%
1,25-dihydroxyvitamin D
25%
Medicine and Dentistry
Hemodialysis
100%
COVID-19
79%
Differential Diagnosis
53%
Kidney Stone
50%
Acute Kidney Injury
50%
Alcohol Liver Cirrhosis
50%
Calciphylaxis
50%
Lipoic Acid
50%
Inappropriate Vasopressin Secretion
50%
Digital Health
50%
Membranous Glomerulonephritis
50%
Diabetes Insipidus
50%
Thrombus
50%
Stent Placement
50%
Hypernatremia
50%
Paraganglioma
50%
(3 Iodobenzyl)guanidine I 131
50%
Dosimetry
50%
Nephropathy
50%
Parvovirus B19
50%
Morphology
50%
Health Equity
50%
Oxalic Acid
50%
Silo-Filler's Disease
50%
ChatGPT-4
50%
Autoimmunity
50%
Scleroderma
50%
Hyponatremia
50%
Epidermal Growth Factor
43%
Idiopathic Pulmonary Fibrosis
39%
Fifth Disease
33%
Tumor Necrosis Factor
33%
Endothelium
33%
Kidney Function
30%
Pathophysiology
26%
Emergency Treatment
26%
Sodium
26%
Patient Satisfaction
25%
Odds Ratio
25%
Public Health
16%
Patient Population
16%
Endothelial Cell Antibody
16%
Quality Improvement
16%
Pulmonary Fibrosis
16%
Kawasaki Disease
16%
Virus
16%
Capillaritis
16%
Capillary
16%
Inflammation
16%
Idiopathic Interstitial Pneumonia
16%
